Generation of MEN1 and DAXX Isogenic Pluripotent Stem Cell Lines to Develop Personalized Therapies Targeting Pancreatic Neuroendocrine Tumours

Project Details

StatusFinished
Effective start/end date1/01/16 → 31/03/17

Funding

  • £74,158.00